Oxford Nanopore Technologies PLC
LSE:ONT

Watchlist Manager
Oxford Nanopore Technologies PLC Logo
Oxford Nanopore Technologies PLC
LSE:ONT
Watchlist
Price: 128.8 GBX 4.89% Market Closed
Market Cap: 1.2B GBX
Have any thoughts about
Oxford Nanopore Technologies PLC?
Write Note

Oxford Nanopore Technologies PLC
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Oxford Nanopore Technologies PLC
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Oxford Nanopore Technologies PLC
LSE:ONT
Cash & Cash Equivalents
ÂŁ220.5m
CAGR 3-Years
40%
CAGR 5-Years
44%
CAGR 10-Years
N/A
Diaceutics PLC
LSE:DXRX
Cash & Cash Equivalents
ÂŁ16.7m
CAGR 3-Years
-13%
CAGR 5-Years
52%
CAGR 10-Years
N/A
G
Genedrive PLC
LSE:GDR
Cash & Cash Equivalents
ÂŁ1.2m
CAGR 3-Years
-31%
CAGR 5-Years
-27%
CAGR 10-Years
-13%
Ergomed PLC
LSE:ERGO
Cash & Cash Equivalents
ÂŁ26m
CAGR 3-Years
-4%
CAGR 5-Years
29%
CAGR 10-Years
N/A
C4X Discovery Holdings PLC
LSE:C4XD
Cash & Cash Equivalents
ÂŁ13.1m
CAGR 3-Years
-5%
CAGR 5-Years
7%
CAGR 10-Years
N/A
hVIVO PLC
LSE:HVO
Cash & Cash Equivalents
ÂŁ37.1m
CAGR 3-Years
36%
CAGR 5-Years
52%
CAGR 10-Years
65%
No Stocks Found

Oxford Nanopore Technologies PLC
Glance View

Market Cap
1.1B GBX
Industry
Life Sciences Tools & Services

Oxford Nanopore Technologies Plc develops proprietary technology platform for the electronic analysis of single molecules. The firm develops sensing technology that uses nanopores - nano-scale holes embedded in electronics, to perform molecular analyses. Its products sequence deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its product includes a sensing platform, which is used for the analysis of various types of molecules, such as proteins. The firm's platform is used by scientific researchers to answer questions about the biology of people, plants, animals, pathogens and environments. The company is also used in applied settings, such as clinical diagnostics, epidemiology and food safety. Its areas of research include microbiology, microbiome, environmental, plant, animal, infectious disease, human genomics, clinical research, cancer, transcriptome and populations genomics. The firm's other products include MinION, GridION, PromethION, VolTRAX, Flongle Flow Cells, PromethION Flow Cells, and MinION and Gridion Flow Cells.

ONT Intrinsic Value
181.2 GBX
Undervaluation 29%
Intrinsic Value
Price

See Also

What is Oxford Nanopore Technologies PLC's Cash & Cash Equivalents?
Cash & Cash Equivalents
220.5m GBP

Based on the financial report for Dec 31, 2023, Oxford Nanopore Technologies PLC's Cash & Cash Equivalents amounts to 220.5m GBP.

What is Oxford Nanopore Technologies PLC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
44%

Over the last year, the Cash & Cash Equivalents growth was -38%. The average annual Cash & Cash Equivalents growth rates for Oxford Nanopore Technologies PLC have been 40% over the past three years , 44% over the past five years .

Back to Top